List of companies in Euclidean Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
23andMe is a biotechnology company based in Mountain View, California providing DNA genetic testing and analysis services. | ||||||
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York. | ||||||
Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis. | ||||||
Kallyope is a New York City, New York based biotechnology company founded in 2015 developing therapeutics to improve human health by better understanding the gut-brain relationship. | ||||||
Create real-world AI applications - at scale and at speed - with the first operational AI platform from Peltarion. | ||||||
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells | ||||||
A food company making dairy-free plant-based milk and dairy products. | ||||||
Alector is a San Francisco, California biotechnology company developing treatments for neurodegeneration and cancer through immuno-neurology and immuno-oncology. | ||||||
ASAPP is a developer of artificial intelligence and machine learning products for automation and human augmentation for customer experiences. The company was founded in 2014 by Marcus Westin and Gustavo Sapoznik. | ||||||
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. | ||||||
Dascena is an Oakland, California-based machine learning company developing algorithms for early diseases intervention and care outcomes. | ||||||
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. | ||||||
Actio Biosciences is a biotechnology company pioneering precision medicine by developing genetically targeted therapies for both rare and common diseases. Leveraging advanced genomics, Actio aims to transform drug discovery through a patient-first, data-driven approach to therapeutic innovation. | ||||||
Savvy Wealth is a New York–based fintech and RIA platform (founded 2021 by Ritik Malhotra & Muller Zhang) that integrates AI-powered advisor tools with in-house financial advisors. |
